Thomas Netticadan

4.0k total citations
96 papers, 3.1k citations indexed

About

Thomas Netticadan is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Thomas Netticadan has authored 96 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Cardiology and Cardiovascular Medicine, 29 papers in Molecular Biology and 23 papers in Pathology and Forensic Medicine. Recurrent topics in Thomas Netticadan's work include Sirtuins and Resveratrol in Medicine (20 papers), Cardiac electrophysiology and arrhythmias (19 papers) and Cardiac Ischemia and Reperfusion (16 papers). Thomas Netticadan is often cited by papers focused on Sirtuins and Resveratrol in Medicine (20 papers), Cardiac electrophysiology and arrhythmias (19 papers) and Cardiac Ischemia and Reperfusion (16 papers). Thomas Netticadan collaborates with scholars based in Canada, Iran and Japan. Thomas Netticadan's co-authors include Naranjan S. Dhalla, Sijo Joseph Thandapilly, Xavier Lieben Louis, Liping Yu, Pema Raj, Rana M. Temsah, Mihir Parikh, Grant N. Pierce, Ali Movahed and Peter Wojciechowski and has published in prestigious journals such as Circulation Research, Diabetes and Scientific Reports.

In The Last Decade

Thomas Netticadan

89 papers receiving 3.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Netticadan Canada 32 1.2k 908 652 639 632 96 3.1k
Ricky Y.K. Man Hong Kong 32 1.3k 1.1× 576 0.6× 463 0.7× 137 0.2× 1.1k 1.7× 130 3.5k
Myung‐Sunny Kim South Korea 35 1.8k 1.6× 233 0.3× 331 0.5× 183 0.3× 819 1.3× 110 3.8k
Israel Ramírez‐Sánchez Mexico 28 772 0.7× 271 0.3× 284 0.4× 169 0.3× 643 1.0× 84 2.2k
Wai San Cheang Macao 32 1.2k 1.0× 294 0.3× 188 0.3× 132 0.2× 645 1.0× 84 3.0k
Milagros Galisteo Spain 24 613 0.5× 190 0.2× 274 0.4× 253 0.4× 811 1.3× 47 2.8k
Ezequiel Álvarez Spain 29 531 0.4× 401 0.4× 197 0.3× 237 0.4× 361 0.6× 82 2.2k
Barbara Wachowicz Poland 29 601 0.5× 183 0.2× 279 0.4× 298 0.5× 354 0.6× 102 2.6k
István Lekli Hungary 27 897 0.8× 281 0.3× 293 0.4× 283 0.4× 277 0.4× 74 2.1k
Junping Kou China 40 2.9k 2.4× 330 0.4× 312 0.5× 120 0.2× 493 0.8× 175 5.2k
A Bertelli Italy 27 752 0.6× 121 0.1× 501 0.8× 906 1.4× 535 0.8× 71 2.4k

Countries citing papers authored by Thomas Netticadan

Since Specialization
Citations

This map shows the geographic impact of Thomas Netticadan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Netticadan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Netticadan more than expected).

Fields of papers citing papers by Thomas Netticadan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Netticadan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Netticadan. The network helps show where Thomas Netticadan may publish in the future.

Co-authorship network of co-authors of Thomas Netticadan

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Netticadan. A scholar is included among the top collaborators of Thomas Netticadan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Netticadan. Thomas Netticadan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Netticadan, Thomas, et al.. (2025). Resveratrol in food systems: challenges, innovations, and health potential. Journal of Functional Foods. 136. 107127–107127.
2.
Akbarzadeh, Samad, Mehdi Alizadeh, Navid Mohammadi, et al.. (2025). Resveratrol improves lipid profile and recovers heart function in postoperative CABG patients. Molecular and Cellular Biochemistry. 480(11). 5793–5803.
3.
Netticadan, Thomas, et al.. (2025). Effects of resveratrol on inflammatory cytokines in COVID-19 patients: a randomized, double-blinded, placebo-controlled clinical trial. Molecular and Cellular Biochemistry. 480(8). 4865–4872.
4.
5.
Parikh, Mihir, Kimberley A. O’Hara, Thane G. Maddaford, et al.. (2024). Beneficial Effects of Dietary Flaxseed on Non-Alcoholic Fatty Liver Disease. Nutrients. 16(4). 466–466. 4 indexed citations
6.
7.
Parikh, Mihir, J. Alejandro Austria, Spencer D. Proctor, et al.. (2021). The Influence of Diet and Sex on the Gut Microbiota of Lean and Obese JCR:LA-cp Rats. Microorganisms. 9(5). 1037–1037. 8 indexed citations
8.
Raj, Pema, Mihir Parikh, Liping Yu, et al.. (2021). Comparative and Combinatorial Effects of Resveratrol and Sacubitril/Valsartan alongside Valsartan on Cardiac Remodeling and Dysfunction in MI-Induced Rats. Molecules. 26(16). 5006–5006. 14 indexed citations
9.
Netticadan, Thomas, et al.. (2016). Expression of cardiac insulin signalling genes and proteins in rats fed a high-sucrose diet: effect of bilberry anthocyanin extract. Genes & Nutrition. 11(1). 8–8. 8 indexed citations
10.
Raj, Pema, Shelley Zieroth, & Thomas Netticadan. (2015). An overview of the efficacy of resveratrol in the management of ischemic heart disease. Annals of the New York Academy of Sciences. 1348(1). 55–67. 47 indexed citations
11.
Thandapilly, Sijo Joseph, Xavier Lieben Louis, Ali Movahed, et al.. (2013). Reduced hemodynamic load aids low-dose resveratrol in reversing cardiovascular defects in hypertensive rats. Hypertension Research. 36(10). 866–872. 41 indexed citations
12.
Movahed, Ali, Liping Yu, Sijo Joseph Thandapilly, Xavier Lieben Louis, & Thomas Netticadan. (2012). Resveratrol protects adult cardiomyocytes against oxidative stress mediated cell injury. Archives of Biochemistry and Biophysics. 527(2). 74–80. 74 indexed citations
13.
Louis, Xavier Lieben, Ryan C. Murphy, Sijo Joseph Thandapilly, Liping Yu, & Thomas Netticadan. (2012). Garlic extracts prevent oxidative stress, hypertrophy and apoptosis in cardiomyocytes: a role for nitric oxide and hydrogen sulfide. BMC Complementary and Alternative Medicine. 12(1). 140–140. 39 indexed citations
14.
Louis, Xavier Lieben, Sijo Joseph Thandapilly, Suresh K. Mohankumar, et al.. (2011). Treatment with low-dose resveratrol reverses cardiac impairment in obese prone but not in obese resistant rats. The Journal of Nutritional Biochemistry. 23(9). 1163–1169. 37 indexed citations
15.
Wojciechowski, Peter, Xavier Lieben Louis, Sijo Joseph Thandapilly, Liping Yu, & Thomas Netticadan. (2010). Potential of Resveratrol in Preventing the Development of Heart Failure. Current Chemical Biology. 4(1). 84–88. 1 indexed citations
16.
Thandapilly, Sijo Joseph, Peter Wojciechowski, Xavier Lieben Louis, et al.. (2009). Resveratrol Prevents the Development of Pathological Cardiac Hypertrophy and Contractile Dysfunction in the SHR Without Lowering Blood Pressure. American Journal of Hypertension. 23(2). 192–196. 141 indexed citations
17.
Rastogi, Sharad, Emmanuelle Sentex, Vijayan Elimban, Naranjan S. Dhalla, & Thomas Netticadan. (2003). Elevated levels of protein phosphatase 1 and phosphatase 2A may contribute to cardiac dysfunction in diabetes. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1638(3). 273–277. 17 indexed citations
18.
Temsah, Rana M., Thomas Netticadan, Ken‐ichi Kawabata, & Naranjan S. Dhalla. (2002). Lack of both oxygen and glucose contributes to I/R-induced changes in cardiac SR function. American Journal of Physiology-Cell Physiology. 283(4). C1306–C1312. 6 indexed citations
19.
Netticadan, Thomas, Rana M. Temsah, Ken‐ichi Kawabata, & Naranjan S. Dhalla. (2002). Ca2+-overload inhibits the cardiac SR Ca2+–calmodulin protein kinase activity. Biochemical and Biophysical Research Communications. 293(2). 727–732. 10 indexed citations
20.
Netticadan, Thomas, Rana M. Temsah, Ken‐ichi Kawabata, & Naranjan S. Dhalla. (2000). Sarcoplasmic Reticulum Ca 2+ /Calmodulin-Dependent Protein Kinase Is Altered in Heart Failure. Circulation Research. 86(5). 596–605. 94 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ricky Y.K. Man Breakdown of academic impact, for papers by Myung‐Sunny Kim Breakdown of academic impact, for papers by Israel Ramírez‐Sánchez Breakdown of academic impact, for papers by Wai San Cheang Breakdown of academic impact, for papers by Milagros Galisteo Breakdown of academic impact, for papers by Ezequiel Álvarez Breakdown of academic impact, for papers by Barbara Wachowicz Breakdown of academic impact, for papers by István Lekli Breakdown of academic impact, for papers by Junping Kou Breakdown of academic impact, for papers by A Bertelli
Rankless by CCL
2026